Miransertib (ARQ-092) is a potent, orally active, selective and allosteric Akt inhibitor with IC50s of 2.7 nM, 14 nM and 8.1 nM for Akt1, Akt2, Akt3, respectively. Miransertib is also a potent the AKT1-E17K mutant protein inhibitor and has the potential for PI3K/AKT-driven tumors and Proteus syndrome research[1]. Miransertib is effective against Leishmania[2].
Molecular Weight:
432.52
Purity:
99.32
CAS Number:
[1313881-70-7]
Formula:
C27H24N6
Target:
Akt,Parasite
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
